Earnings call transcript: ARS Pharmaceuticals shares fall after Q2 2026 report
What it means
- What to watch: A rough print is one data point; a lowered outlook is a trend, and that is what tends to stick.
- How the stock is trading: $SPRY +0.19% in the latest session.
- Timing: Filed after the close: the price beside it finished its day before the story existed, so the next session gets the first real vote.
Where the stock stands
$SPRY last traded at $2.66, +0.19% on the session. That puts it 80% shy of its 52-week high of $13.15 and 8.8% clear of its low of $2.44 — within a tenth of its 52-week low. Over the year it has ranged 439% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $SPRY page.
How much coverage it is getting
This is the only story Wook has logged on $SPRY in the last 30 days — a quiet name that just got a headline. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
Earnings stories turn less on the headline numbers than on how they compare with what analysts expected, and on guidance for next quarter. A beat with weak guidance can land worse than a miss with a raised outlook — markets grade on the curve. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.
Coming up
$SPRY earnings in 3 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
The $SPRY page has the full chart, the filings and the valuation model behind every figure here. Comparing how two or three outlets frame the same story is the fastest way to separate the facts from the angle. And Wook AI, up top, will happily do the math — how far $SPRY sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Earnings. It reads bearish at medium severity because of “fall” in the wording, with nothing on the bullish side to offset it. It was matched to $SPRY. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 13, 2026. $SPRY has moved -53.01% ($5.65 to $2.65). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.